Akt Inhibitor MK2206 in Treating Patients With Recurrent or Advanced Endometrial Cancer

This study is ongoing, but not recruiting participants.

Sponsor:

Information provided by (Responsible Party):

National Cancer Institute (NCI)

ClinicalTrials.gov Identifier:

NCT01307631

First received: March 1, 2011

Last updated: June 14, 2016

Last verified: June 2016

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Primary Completion Date:	January 2016 (Final data collection date for primary outcome measure)